I
Ioan Sporea
Researcher at Fudan University
Publications - 379
Citations - 11803
Ioan Sporea is an academic researcher from Fudan University. The author has contributed to research in topics: Transient elastography & Elastography. The author has an hindex of 44, co-authored 328 publications receiving 9652 citations.
Papers
More filters
Journal ArticleDOI
The age influence the kidney stiffness assessed by means of Acoustic Radiation Force Impulse (ARFI) elastography
Simona Bota,Flaviu Bob,Ioan Sporea,Roxana Sirli,A Popescu,Mirela Danila,F. Gadalean,L Petrica,A Schiller +8 more
Journal ArticleDOI
What is new in liver elastography
TL;DR: In daily practice, many hepatological conditions, such as chronic viral hepatitis, non-alcoholic and alcoholic fatty liver disease (NAFLD and ALD, respectively) need evaluation.
Journal ArticleDOI
Tu1024 Which Elastographic Method (Transient Elastography or ARFI) is More Useful for Liver Fibrosis Evaluation in Patients With Chronic Hepatitis C? - an International Multicenter Study
Ioan Sporea,Simona Bota,Roxana Sirli,Radu Badea,Monica Lupsor,Hidetsugu Saito,Hirotoshi Ebinuma,Mireen Friedrich-Rust,Christoph Sarrazin,Fabio Piscaglia,Alberto Borghi,Arnulf Ferlitsch,Markus Peck-Radosavljevic,Alina Popescu,Mirela Danila +14 more
TL;DR: Is Acoustic Radiation Force Impulse Elastography (ARFI) a Useful Method for Noninvasive Fibrosis Evaluation in Patients With Chronic Hepatitis C?
Journal ArticleDOI
Liver Steatosis: Better Predictor of CKD in MAFLD Than Liver Fibrosis as Determined by Transient Elastography With Controlled Attenuation Parameter
Luciana Marc,Adelina Mihaescu,Raluca Lupusoru,Iulia Grosu,Florica Gadalean,Flaviu Bob,Lazar Chisavu,Niculina Olariu,Vlad Tucicovschi,Bogdan Timar,Ioan Sporea,Romulus Timar,Adalbert Schiller +12 more
TL;DR: In patients with MAFLD, CAP-assessment steatosis appears to be a better predictor of CKD compared to LSM-assessed hepatic fibrosis.
Book ChapterDOI
Quantification of Liver Steatosis
TL;DR: Fatty infiltration of the liver can be assessed by standard ultrasound, by controlled attenuation parameter (CAP) using the FibroScan device or, more recently, by ultrasound systems that evaluate the attenuation in the liver.